{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:38:58Z","timestamp":1787503138262,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1097\/med.0000000000000050","type":"journal-article","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T13:41:43Z","timestamp":1392212503000},"page":"140-145","source":"Crossref","is-referenced-by-count":6,"title":["Do statins increase the risk of diabetes or is it guilt by association?"],"prefix":"10.1097","volume":"21","author":[{"given":"Michael","family":"Mogadam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20211004","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/archinternmed.2011.625","article-title":"Statin use and risk of diabetes mellitus in postmenopausal women in the Womens Health Initiative.","volume":"172","author":"Culver","year":"2012","journal-title":"Arch Intern Med"},{"key":"R2-11-20211004","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomized statin trials.","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"R3-11-20211004","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.2337\/dc12-1756","article-title":"Statins and risk of diabetes: an analysis of electronic medical records to evaluate possible bias due to differential survival.","volume":"36","author":"Danaei","year":"2013","journal-title":"Diabetes Care"},{"key":"R4-11-20211004","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.","volume":"380","author":"Ridker","year":"2012","journal-title":"Lancet"},{"key":"R6-11-20211004","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.jacc.2010.10.047","article-title":"Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials.","volume":"57","author":"Waters","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R7-11-20211004","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.","volume":"305","author":"Preiss","year":"2011","journal-title":"JAMA"},{"key":"R8-11-20211004","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jacc.2012.09.042","article-title":"Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes.","volume":"61","author":"Waters","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R11-11-20211004","doi-asserted-by":"crossref","first-page":"526","DOI":"10.7326\/0003-4819-158-7-201304020-00004","article-title":"Discontinuation of statins in routine care setting.","volume":"158","author":"Zhang","year":"2013","journal-title":"Ann Intern Med"},{"key":"R12-11-20211004","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jacc.2011.03.025","article-title":"Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis).","volume":"58","author":"Yeboah","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R14-11-20211004","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0140-6736(12)61426-3","article-title":"Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidemia: a cohort study.","volume":"381","author":"Kokkinos","year":"2013","journal-title":"Lancet"},{"key":"R15-11-20211004","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacl.2013.04.001","article-title":"Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association.","volume":"7","author":"Bays","year":"2013","journal-title":"J Clin Lipidol"},{"key":"R16-11-20211004","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.amjcard.2012.09.034","article-title":"Effects of niacin on glucose levels, coronary stenosis progression, and clinical events in subjects with normal baseline glucose levels (100mgdl): a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), HDL-Atherosclerosis Treatment Study (HATS), Armed Forces Regression Study (AFREGS), and Carotid Plaque Composition by MRI during lipid-lowering (CPC) study.","volume":"111","author":"Phan","year":"2013","journal-title":"Am J Cardiol"},{"key":"R17-11-20211004","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.","volume":"142","author":"Chalasoni","year":"2012","journal-title":"Gastroenterology"},{"key":"R18-11-20211004","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1053\/j.gastro.2010.08.055","article-title":"Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C.","volume":"140","author":"Rao","year":"2011","journal-title":"Gastroenterology"},{"key":"R19-11-20211004","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2012.10.005","article-title":"Statins are associated with a reduced risk of hepatocellular cancer: a systemic review and meta-analysis.","volume":"144","author":"Singh","year":"2013","journal-title":"Gastroenterology"},{"key":"R20-11-20211004","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1001\/jama.2010.651","article-title":"Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes.","volume":"303","author":"Boutron","year":"2010","journal-title":"JAMA"},{"key":"R22-11-20211004","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1001\/jama.2009.1756","article-title":"The need for large-scale randomized evidence without undue emphasis on small trials, meta-analyses, or subgroup analyses.","volume":"302","author":"Hennekens","year":"2009","journal-title":"JAMA"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201404000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T06:12:53Z","timestamp":1633500773000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201404000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0000000000000050","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}